Diabetes Care
29:S3
2006
© 2006 by the American Diabetes Association
Diabetes Care 29:S3, 2006
© 2006 by the American Diabetes Association, Inc.
SUMMARY OF REVISIONS ORIGINAL ARTICLE |
Summary of Revisions for the 2006 Clinical Practice Recommendations
 |
INTRODUCTION
|
|---|
Beginning with the 2005 supplement, the Clinical Practice Recommendations contained only the "Standards of Medical Care in Diabetes" and selected other position statements. This change was made to emphasize the importance of the "Standards" as the best source to determine ADA recommendations. The position statements in the supplement are updated yearly. Position statements not included in the supplement will be updated as necessary and republished when completed. A list of the position statements not included in this supplement appears on p. S75.
 |
Format changes
|
|---|
- Page numbers now appear in the "Contents" for ease in locating particular sections
- Recommendations are now listed at the beginning of each section
 |
Additions to the Standards of Medical Care in Diabetes
|
|---|
- Medical nutrition therapy (MNT)extensively enhanced
- Diabetes self-management education (DSME)
- Physical activity
- Neuropathy
 |
Summary of Revisions to Standards of Medical Care for Diabetes
|
|---|
- Assessment of glycemic control
- Use of point-of-care testing for HbA1c (A1C) allows for timely decisions on therapy changes, when needed (E)
- Glycemic goals
- The A1C goal for patients in general is <7% (B)
- The A1C goal for the individual patient is an A1C as close to normal (<6%) as possible without significant hypoglycemia (E)
- Nephropathy
- To reduce the risk of nephropathy, protein intake should be limited to the Recommended Dietary Allowance (RDA) (0.8 g/kg) in those with any degree of chronic kidney disease (CKD) (B)
- Serum creatinine should be measured at least annually for the estimation of glomerular filtration rate (GFR) in all adults with diabetes regardless of the degree of urine albumin excretion. The serum creatinine alone should not be used as a measure of kidney function but rather used to estimate GFR and stage the level of CKD (E)
 |
Members of the Professional Practice Committee
|
|---|
Vivian Fonseca, MD, Chair
Evan M. Benjamin, MD
Lawrence Blonde, MD
Kenneth Copeland, MD
Marjorie L. Cypress, MS, RN, CDE
Hertzel C. Gerstein, MD, Msc, FRCPC
Irl Hirsch, MD
Steven Kahn, MB, ChB
Elizabeth Mayer-Davis, MS, PhD, RD
James Meigs, MD, MPH
Michael P. Pignone, MD, MPH
Janet H. Silverstein, MD
Geralyn R. Spollett, MSN, C-ANP, CDE
Judith Wylie-Rossett, RD, EdD Nathaniel G. Clark, MD, MS, RD (Staff)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol.,
August 14, 2007;
50(7):
e1 - e157.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Morse and J. A. Kovacs
Metabolic and skeletal complications of HIV infection: the price of success.
JAMA,
August 16, 2006;
296(7):
844 - 854.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|
|